Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant
tumours that can arise at any point of the biliary tree. Their incidence is increasing globally …

Malignant liver tumours include a wide range of primary and secondary tumours. Although
surgery remains the mainstay of curative treatment, modern therapies integrate a variety of …

Management of primary or secondary sclerosing cholangitis is challenging. These Clinical
Practice Guidelines have been developed to provide practical guidance on debated topics …

Surgical resection is the only potentially curative treatment for patients with
cholangiocarcinoma. For both perihilar cholangiocarcinoma (pCCA) and intrahepatic …

Cholangiocarcinoma (CCA) is a heterogeneous group of neoplasms of the bile ducts and
represents the second most common hepatic cancer after hepatocellular carcinoma; it is sub …

Cholangiocarcinoma (CCA) encompasses a group of malignancies that can arise at any
point in the biliary tree. Although considered a rare cancer, the incidence of CCA is …

Simple Summary The treatment of peri-hilar (h-CCA) and intrahepatic (i-CCA)
cholangiocarcinoma is an evolving field in hepato-pancreato-biliary surgery. Continuous …

Objective: To define benchmark values for liver transplantation (LT) in patients with perihilar
cholangiocarcinoma (PHC) enabling unbiased comparisons. Background: Transplantation …

Objective: To evaluate the efficacy and safety of combined vascular resection (VR) in
advanced perihilar cholangiocarcinoma (PHC). Summary of Background Data: Hepatectomy …

Objective: To systematically review studies reporting survival data following neoadjuvant
chemoradiation and orthotopic liver transplantation (NCR-OLT) for unresectable perihilar …